Products
Online Inquiry
Arjunolic acid
Cat. No.:
0225LY-0748
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Arjunolic acid possesses anti-inflammatory, antioxidant, antinociceptive, and anticholinesterasic (AChE/BuChE) properties, making it a potential lead for developing multi-functional treatments for Alzheimer's disease.
Synonym:
465-00-9; (4aS,6aR,6aS,6bR,8aR,9R,10R,11R,12aR,14bS)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; 2,3,23-Trihydroxyolean-12-en-28-oic acid; 2alpha,3beta-24-trihydroxyolean-12-en-28-oic acid; (2alpha,3beta)-2,3,23-trihydroxyolean-12-en-28-oic acid; Olean-12-en-28-oic acid, 2,3,23-trihydroxy-, (2alpha,3beta,4alpha)-
CAS No.:
465-00-9
Compound CID:
73641
Formula:
C30H48O5
Formula Weight:
488.7
Specification
Relative Density:
1.19 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Arjunolic acid can be used in cardiovascular research to study its antioxidant properties and its role in protecting against cardiac injury.
Library Information
Target:
IL receptor; AChE; JNK; TNF receptor
Receptor:
IL-1 receptor; AChE; JNK; TNF-α receptor
Pathways:
Apoptosis; MAPK; Neuronal signaling; Immunology/Inflammation; Metabolism; NF-κB
Plate Number:
AOCL-10
Plate Location:
f5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
50 mg/mL; 102.31 mM
